![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SH2D5 |
Gene summary for SH2D5 |
![]() |
Gene information | Species | Human | Gene symbol | SH2D5 | Gene ID | 400745 |
Gene name | SH2 domain containing 5 | |
Gene Alias | SH2D5 | |
Cytomap | 1p36.12 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q6ZV89 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
400745 | SH2D5 | C04 | Human | Oral cavity | OSCC | 6.33e-06 | 3.26e-01 | 0.2633 |
400745 | SH2D5 | C21 | Human | Oral cavity | OSCC | 5.81e-05 | 1.76e-01 | 0.2678 |
400745 | SH2D5 | C30 | Human | Oral cavity | OSCC | 1.34e-24 | 7.84e-01 | 0.3055 |
400745 | SH2D5 | C06 | Human | Oral cavity | OSCC | 1.27e-02 | 3.48e-01 | 0.2699 |
400745 | SH2D5 | SYSMH3 | Human | Oral cavity | OSCC | 1.19e-23 | 5.09e-01 | 0.2442 |
400745 | SH2D5 | SYSMH5 | Human | Oral cavity | OSCC | 9.25e-09 | 2.46e-01 | 0.0647 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Oral Cavity | ![]() | EOLP: Erosive Oral lichen planus |
LP: leukoplakia | ||
NEOLP: Non-erosive oral lichen planus | ||
OSCC: Oral squamous cell carcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SH2D5 | SNV | Missense_Mutation | c.1228N>T | p.Leu410Phe | p.L410F | Q6ZV89 | protein_coding | deleterious_low_confidence(0.03) | possibly_damaging(0.804) | TCGA-A8-A08R-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SH2D5 | SNV | Missense_Mutation | c.862G>A | p.Glu288Lys | p.E288K | Q6ZV89 | protein_coding | deleterious(0) | benign(0.001) | TCGA-C8-A26Y-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SH2D5 | SNV | Missense_Mutation | rs751553158 | c.845N>T | p.Ser282Leu | p.S282L | Q6ZV89 | protein_coding | tolerated(0.69) | benign(0) | TCGA-Z7-A8R6-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxol | CR |
SH2D5 | SNV | Missense_Mutation | novel | c.1255C>A | p.Leu419Met | p.L419M | Q6ZV89 | protein_coding | deleterious_low_confidence(0.04) | possibly_damaging(0.648) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
SH2D5 | SNV | Missense_Mutation | c.1219N>G | p.Leu407Val | p.L407V | Q6ZV89 | protein_coding | tolerated_low_confidence(0.06) | benign(0.052) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
SH2D5 | SNV | Missense_Mutation | rs751663789 | c.1222N>T | p.Arg408Trp | p.R408W | Q6ZV89 | protein_coding | tolerated_low_confidence(0.16) | benign(0) | TCGA-A6-A567-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | PD |
SH2D5 | SNV | Missense_Mutation | rs760903091 | c.1003N>T | p.Arg335Cys | p.R335C | Q6ZV89 | protein_coding | deleterious(0) | possibly_damaging(0.742) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SH2D5 | SNV | Missense_Mutation | rs750727956 | c.1054N>T | p.Arg352Cys | p.R352C | Q6ZV89 | protein_coding | deleterious(0) | possibly_damaging(0.653) | TCGA-DM-A1D0-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SH2D5 | SNV | Missense_Mutation | rs369171247 | c.661C>T | p.Arg221Cys | p.R221C | Q6ZV89 | protein_coding | tolerated(0.18) | probably_damaging(0.984) | TCGA-DM-A1HB-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
SH2D5 | SNV | Missense_Mutation | rs745377516 | c.752N>A | p.Arg251His | p.R251H | Q6ZV89 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-G4-6302-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
400745 | SH2D5 | NA | gemcitabine | GEMCITABINE | 22838950 |
Page: 1 |